Cargando…
Rescue therapy for refractory status asthmaticus with updosed omalizumab adjusted for IgE level, body weight and effect
Status asthmaticus is a life-threatening condition with a high mortality rate of up to 10.3% [1]. Milger et al. recently described a rapid clinical improvement and a reduction in serum IgE levels in a patient with status asthmaticus who received salvage therapy with omalizumab [2]. This treatment is...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889270/ https://www.ncbi.nlm.nih.gov/pubmed/35251928 http://dx.doi.org/10.1016/j.rmcr.2022.101614 |